A panel of experts organized by the National Institutes of Health on Tuesday announced a "living document" of guidelines regarding treatment options for the coronavirus, but warned that the public should be wary of any informal studies touting these medicines.
The big picture: The guidelines will be updated as new information emerges from peer-reviewed scientific literature and other authoritative sources. Antivirals like hydroxychloroquine and Gilead's remdesivir, as well as immunotherapies like the transfer of plasma from former patients, are among the options under investigation.
Go deeper: What's next in the race for a coronavirus treatment
